Stonepine Capital Management’s ImageneBio Inc IMA Stock Holding History

Stonepine Capital Management’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$264K	Buy	+57,663	New	+$313K	0.17%	63

Other funds holding IMA

Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

BCM

BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $140M AUM 44.76% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Aldebaran Capital Carmel, Indiana $139M AUM 35.88% 1-Year Est. Return

Stonepine Capital Management's IMA Position: Q3 2026 in Review

Stonepine Capital Management opened a new position in ImageneBio Inc (IMA) in Q3 2026: 57,663 shares worth $264K. The stake represents 0.17% of the portfolio and ranks #63 among its holdings.

21 funds tracked by Wall St. Rank hold IMA as of Q3 2026.

Stonepine Capital Management held 57,663 shares of ImageneBio Inc worth $264K as of Q3 2026.
ImageneBio Inc was a new Stonepine Capital Management position in Q3 2026.
ImageneBio Inc made up 0.17% of Stonepine Capital Management's portfolio in Q3 2026, its #63 holding.
21 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2026.

Based on Stonepine Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.